Tema Oncology ETF Rating $24.45 +0.14 (+0.58%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Tema Oncology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.78Holdings in CANC have an aggregate rating of Moderate Buy based on 600 analyst ratings issued in the past year covering 44 companies (84.6% of the portfolio).CANC Aggregate Price Target$24.45High Prediction$24.45Average Prediction$24.45Low Prediction$24.45Holdings in CANC have an aggregate price target of $24.45 and a range of $24.45 to $24.45 covering 44 companies (84.6% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 CANC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.00%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6599 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume5.56%GILDGilead Sciences$92.57+1.6%4.4898 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume4.40%BPMCBlueprint Medicines$90.14+1.4%2.5701 of 5 stars2.71$122.11 35.5%21Insider Trade4.34%ARGXargenx$623.82-0.4%3.0025 of 5 stars2.91$639.78 2.6%22Analyst ForecastShort Interest ↓Positive News4.22%INCYIncyte$68.84+2.7%4.7054 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume4.13%RVMDRevolution Medicines$44.06+1.8%4.5486 of 5 stars3.09$65.82 49.4%11Insider Trade4.06%ILMNIllumina$136.02+1.5%4.482 of 5 stars2.70$165.95 22.0%20High Trading Volume3.33%EXELExelixis$33.29-1.2%4.5075 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume2.92%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume2.59%MREOMereo BioPharma Group$3.35+1.8%2.0953 of 5 stars3.33$7.40 120.9%6High Trading Volume2.47%GMABGenmab A/S$20.31+1.1%4.2345 of 5 stars2.56$45.20 122.6%9Positive NewsHigh Trading Volume2.46%GHGuardant Health$31.67+1.7%4.1134 of 5 stars3.00$40.60 28.2%152.46%SWTXSpringWorks Therapeutics$35.59+2.3%2.0068 of 5 stars3.00$69.50 95.3%62.41%CRSPCRISPR Therapeutics$40.72+0.8%2.5528 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume2.27%AGIOAgios Pharmaceuticals$35.42-1.1%4.2892 of 5 stars2.50$56.33 59.0%8Analyst ForecastHigh Trading Volume2.25%BGNEBeiGene$176.50+1.0%2.6145 of 5 stars2.75$253.69 43.7%82.07%NUVLNuvalent$84.22-0.5%2.1944 of 5 stars2.85$112.60 33.7%13Insider TradeNews CoveragePositive NewsHigh Trading Volume2.00%SDGRSchrödinger$19.44+0.7%2.3678 of 5 stars2.82$32.90 69.2%11Positive News1.77%DAWNDay One Biopharmaceuticals$12.79+2.6%1.6211 of 5 stars3.00$35.71 179.2%9High Trading Volume1.77%EXASExact Sciences$59.40+5.9%4.4883 of 5 stars2.94$72.94 22.8%181.56%NTLAIntellia Therapeutics$12.18+0.8%4.2166 of 5 stars2.72$54.94 351.0%18High Trading Volume1.50%CLDXCelldex Therapeutics$25.14-0.9%2.6659 of 5 stars2.88$62.25 147.6%8Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.42%AMGNAmgen$263.38+0.8%4.4684 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume1.39%LNTHLantheus$89.29-2.9%4.3778 of 5 stars3.00$131.86 47.7%7Analyst ForecastHigh Trading Volume1.19%MRUSMerus$41.85-0.6%2.7827 of 5 stars3.14$85.64 104.6%141.18%ACLXArcellx$75.54+0.4%3.1329 of 5 stars3.13$105.93 40.2%15Positive NewsHigh Trading Volume1.01%BNTXBioNTech$113.08+1.6%2.0844 of 5 stars2.82$140.76 24.5%170.95%COGTCogent Biosciences$7.84+0.5%1.9533 of 5 stars2.57$14.83 89.2%70.95%NRIXNurix Therapeutics$19.83-1.0%2.5066 of 5 stars2.94$30.35 53.1%17News CoverageHigh Trading Volume0.86%IDYAIDEAYA Biosciences$25.61+3.3%4.3203 of 5 stars2.94$53.67 109.6%16Analyst ForecastHigh Trading Volume0.83%LEGNLegend Biotech$34.08+0.2%1.548 of 5 stars3.00$81.54 139.3%130.79%ORICORIC Pharmaceuticals$8.21+6.8%3.6849 of 5 stars3.00$18.29 122.7%8Insider TradeGap Down0.78%BCYCBicycle Therapeutics$14.68-2.1%3.6062 of 5 stars2.78$35.25 140.1%9Analyst ForecastInsider TradeAnalyst RevisionNews Coverage0.75%MRNAModerna$39.39-0.4%4.2706 of 5 stars2.14$79.50 101.8%22Analyst DowngradeHigh Trading Volume0.74%RCUSArcus Biosciences$15.50+0.3%2.6476 of 5 stars3.00$34.00 119.4%9News CoverageHigh Trading Volume0.68%IMCRImmunocore$28.33-0.3%2.4974 of 5 stars2.54$65.64 131.7%13Short Interest ↓0.68%CGEMCullinan Therapeutics$11.60+5.9%1.8003 of 5 stars3.00$31.67 173.0%7News Coverage0.64%TERNTerns Pharmaceuticals$5.86-3.1%4.2412 of 5 stars2.80$18.30 212.3%5Positive NewsGap DownHigh Trading Volume0.62%JANXJanux Therapeutics$56.83+0.1%3.6708 of 5 stars3.00$89.90 58.2%12Positive News0.55%RLAYRelay Therapeutics$4.16-2.3%2.2525 of 5 stars2.91$20.50 392.8%11Insider TradeHigh Trading Volume0.54%CGONCG Oncology$28.67+2.3%2.1551 of 5 stars3.11$63.88 122.8%9Insider TradeHigh Trading Volume0.53%JSPRJasper Therapeutics$21.57+0.2%2.3297 of 5 stars3.00$73.38 240.2%10Positive News0.49%CRBPCorbus Pharmaceuticals$13.00-2.5%3.8067 of 5 stars3.11$62.00 376.9%90.46%ARVNArvinas$18.48+3.6%2.0251 of 5 stars2.93$63.50 243.6%15High Trading Volume This page (NASDAQ:CANC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts